HomeCompareTSYS vs JNJ

TSYS vs JNJ: Dividend Comparison 2026

TSYS yields 40.08% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TSYS wins by $212.9K in total portfolio value
10 years
TSYS
TSYS
● Live price
40.08%
Share price
$4.99
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$232.9K
Annual income
$39,418.01
Full TSYS calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TSYS vs JNJ

📍 TSYS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTSYSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TSYS + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TSYS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TSYS
Annual income on $10K today (after 15% tax)
$3,406.81/yr
After 10yr DRIP, annual income (after tax)
$33,505.31/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TSYS beats the other by $32,801.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TSYS + JNJ for your $10,000?

TSYS: 50%JNJ: 50%
100% JNJ50/50100% TSYS
Portfolio after 10yr
$126.5K
Annual income
$20,122.89/yr
Blended yield
15.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TSYS
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TSYS buys
0
JNJ buys
0
No recent congressional trades found for TSYS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTSYSJNJ
Forward yield40.08%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$232.9K$20.0K
Annual income after 10y$39,418.01$827.78
Total dividends collected$175.3K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TSYS vs JNJ ($10,000, DRIP)

YearTSYS PortfolioTSYS Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$14,708$4,008.02$10,676$355.77+$4.0KTSYS
2$21,247$5,509.34$11,407$389.39+$9.8KTSYS
3$30,172$7,438.03$12,198$426.53+$18.0KTSYS
4$42,156$9,871.56$13,056$467.62+$29.1KTSYS
5$57,997$12,889.98$13,987$513.12+$44.0KTSYS
6$78,630$16,573.49$14,998$563.56+$63.6KTSYS
7$105,134$20,999.79$16,098$619.52+$89.0KTSYS
8$138,735$26,241.32$17,295$681.69+$121.4KTSYS
9$180,809$32,362.64$18,599$750.82+$162.2KTSYS
10$232,883$39,418.01$20,022$827.78+$212.9KTSYS

TSYS vs JNJ: Complete Analysis 2026

TSYSStock

TeleCommunication Systems, Inc. develops network applications that enable the delivery of Internet content, short messages, and enhanced data communication services to a variety of wireless devices. The Company's wireless Internet gateway enables wireless carriers and enterprises to provide customers and employees with real-time, wireless access to Internet content and e-mail.

Full TSYS Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TSYS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TSYS vs SCHDTSYS vs JEPITSYS vs OTSYS vs KOTSYS vs MAINTSYS vs ABBVTSYS vs MRKTSYS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.